Skip to main content
. 2022 May 27;12:785350. doi: 10.3389/fonc.2022.785350

Table 4.

Median OS as calculated from the end of treatment (immunotherapy or radiation) or decision to start immunotherapy.

Endpoint for OS Immunotherapy Timing Median OS from SBRT (months) p-value
End of treatment Before 3.088 0.064
Concurrent/After 9.331
Decision to start immunotherapy Before 10.02 0.91
Concurrent/After 12.65

OS, Overall survival; SBRT, Stereotactic Body Radiotherapy.